The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperlipidemia

NCT03944109 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia

Interventions

DRUG: SHR-1209
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.